The Patent Finder

Prothera, Inc.

Also on record
Records under this name other than patents Prothera, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Prothera, Inc.

PatentTitleStatus Expires Confidence
US 9,737,591Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis
Lapsed on the fee record
Ended Aug 22, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2025From the USPTO record
US 11,078,516Inhibition and treatment of gastrointestinal biofilms
Lapsed on the fee record
Ended Aug 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2025From the USPTO record
US 9,579,353Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
Lapsed on the fee record
Ended Feb 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2025From the USPTO record
US 8,383,101Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
Lapsed on the fee record
Ended Feb 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 26, 2025From the USPTO record
US 9,358,274Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
Lapsed on the fee record
Ended Jun 7, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2024From the USPTO record
US 9,987,337Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
Lapsed on the fee record
Ended Jun 5, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2022From the USPTO record
US 8,728,467Methods comprising serratia peptidase for inhibition of osteomyelitis
Lapsed on the fee record
Ended May 20, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2022From the USPTO record
US 9,931,381Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
Lapsed on the fee record
Ended Apr 3, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2022From the USPTO record
US 9,387,236Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
Lapsed on the fee record
Ended Jul 12, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 12, 2020From the USPTO record
US 6,808,708Compositions and methods relating to reduction of symptoms of autism
Term ended
Term ended Apr 17, 2020 · From the USPTO record
Term endedTerm ended Apr 17, 2020From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited